Evidence map›Paper›PMID 18403674›Full record

ArticleScience (New York, N.Y.)2008

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica.

Catherine Dostert, Virginie Pétrilli, Robin Van Bruggen, Chad Steele, Brooke T Mossman, Jürg Tschopp

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,328 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,328citing papers in PubMed, 2 pooled it
65.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,328 citing papers in PubMed, 2 syntheses or guidelines pooled it, 2,634 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Inflammasomes in respiratory diseases: from disease pathogenesis to drug development and use of multi-omics.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Exploring the Mechanism of Tannic Acid AgainstPathogens (Basel, Switzerland) · 2026
    Article
  20. Article

1,268 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Catherine DostertDepartment of Biochemistry, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges, Switzerland.
Virginie Pétrilli
Robin Van Bruggen
Chad Steele
Brooke T Mossman
Jürg Tschopp
University of Lausanne · CHUniversity of Vermont · US

Funding

PATHOLOGY, VIROLOGY, AND ANIMAL COREP01CA114047 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI CARBONE, MICHELE · 2006 to 2010
$8.0M
SIGNALING IN EPITHELIAL INJURY, PROLIFERATION &FIBROSISP01HL067004 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MOSSMAN, BROOKE TAYLOR · 2001 to 2005
$7.6M
NCI NIH HHS P01 CA114047NHLBI NIH HHS P01HL67004
6 · The paper itself

Abstract

The inhalation of airborne pollutants, such as asbestos or silica, is linked to inflammation of the lung, fibrosis, and lung cancer. How the presence of pathogenic dust is recognized and how chronic inflammatory diseases are triggered are poorly understood. Here, we show that asbestos and silica are sensed by the Nalp3 inflammasome, whose subsequent activation leads to interleukin-1beta secretion. Inflammasome activation is triggered by reactive oxygen species, which are generated by a NADPH oxidase upon particle phagocytosis. (NADPH is the reduced form of nicotinamide adenine dinucleotide phosphate.) In a model of asbestos inhalation, Nalp3-/- mice showed diminished recruitment of inflammatory cells to the lungs, paralleled by lower cytokine production. Our findings implicate the Nalp3 inflammasome in particulate matter-related pulmonary diseases and support its role as a major proinflammatory "danger" receptor.

Indexed as

AnimalsAsbestosCarrier ProteinsHumansImmunityInflammationInflammation MediatorsInterleukin-1betaMacrophagesMiceNLR Family, Pyrin Domain-Containing 3 ProteinSilicon DioxideAsbestosCarrier ProteinsInflammation MediatorsInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseSilicon Dioxide

Identifiers

PMID18403674
PMCPMC2396588
OpenAlexW2009004909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.